Home » Newsletters » BioWorld

BioWorld

June 27, 2016

View Archived Issues

BioWorld stock report for public biotechnology companies

The week's biggest gainers and losers

Money raised by biotech: Jan. 1 - June 23, 2016

Money raised by biotech in 2016 vs. 2015

Pending biopharmaceutical mergers and acquisitions

Completed biopharmaceutical mergers and acquisitions: March 1 - June 23, 2016

Top 10 biopharmaceutical M&As in 2016

Week in Washington

Word on the street

Week in review

Nanotech: Small drugs, myriad of opportunities

From cancer to psoriasis, companies are using different nanotechnology platforms to deliver drugs more effectively. Read More

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...